.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Mallinckrodt
Baxter
Accenture
Fuji
Express Scripts
Federal Trade Commission
Cantor Fitzgerald
Medtronic
Argus Health

Generated: December 18, 2017

DrugPatentWatch Database Preview

ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Esmolol Hydrochloride In Plastic Container, and when can generic versions of Esmolol Hydrochloride In Plastic Container launch?

Esmolol Hydrochloride In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. There are four patents protecting this drug.

This drug has forty-three patent family members in twenty-five countries.

The generic ingredient in ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER is esmolol hydrochloride. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.

Summary for ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER

Drug patent expirations by year for ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER

Pharmacology for ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hq Spclt PharmaESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINEResmolol hydrochlorideSOLUTION;INTRAVENOUS205703-001Apr 7, 2016RXYesYes► Subscribe► SubscribeY► Subscribe
Hq Spclt PharmaESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINEResmolol hydrochlorideSOLUTION;INTRAVENOUS205703-001Apr 7, 2016RXYesYes► Subscribe► SubscribeY► Subscribe
Hq Spclt PharmaESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINEResmolol hydrochlorideSOLUTION;INTRAVENOUS205703-001Apr 7, 2016RXYesYes► Subscribe► SubscribeY► Subscribe
Hq Spclt PharmaESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINEResmolol hydrochlorideSOLUTION;INTRAVENOUS205703-001Apr 7, 2016RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER

Country Document Number Estimated Expiration
Slovenia1368019► Subscribe
Poland216192► Subscribe
Denmark1368019► Subscribe
China105263809► Subscribe
European Patent Office1368019► Subscribe
TaiwanI277414► Subscribe
China1775207► Subscribe
Japan5778384► Subscribe
Japan2016515513► Subscribe
Austria341319► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Citi
Queensland Health
Deloitte
Accenture
Express Scripts
Daiichi Sankyo
Federal Trade Commission
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot